[Expression of nuclear factor-kappaB in bone marrow cells from patients with acute leukemia and its relationship with P21, MMP-2 and MMP-9]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):243-5.
[Article in Chinese]

Abstract

To investigate the expression of NF-kappaB in acute leukemia and its relationship with P21, and matrix metalloproteinases (MMP), the expression of NF-kappaB, P21, MMP-2 and MMP-9 in bone marrow cells from patients with acute leukemia (AL) was detected using immunocytochemical technique. The results showed that the expression ratios of NF-kappaB, P21, MMP-2 and MMP-9 in untreated AL group were significantly higher than those in remission and normal control groups (P < 0.05), and no obvious difference was seen between remission and normal control groups. The expression of NF-kappaB was correlated with that of P21, MMP-2 and MMP-9 (r = 0.767, 0.729 and 0.803, respectively, P < 0.05). This study indicated that P21 protein, encoded by oncogene Ras, and NF-kappaB were super-expressed in leukemia cells. In conclusion, after activation by Ras, NF-kappaB combined with the kappaB sequences of MMP-2 and MMP-9 genes, then upregulated their expression. MMP might enhance the degradative function of leukemic cell, thus to make cells easier to cross through the bone marrow barrier and release into blood.

Publication types

  • English Abstract

MeSH terms

  • Acute Disease
  • Adult
  • Bone Marrow Cells / metabolism*
  • Female
  • Humans
  • Immunohistochemistry
  • Leukemia / drug therapy
  • Leukemia / metabolism*
  • Leukemia / pathology
  • Male
  • Matrix Metalloproteinase 2 / biosynthesis*
  • Matrix Metalloproteinase 9 / biosynthesis*
  • NF-kappa B / biosynthesis*
  • Proto-Oncogene Proteins p21(ras) / biosynthesis*
  • Remission Induction

Substances

  • NF-kappa B
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)